Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Lisata Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q4 2023
- Shares held
- 738.8K
- −3.31K (−0.4%) vs. Q4 2023
- Total value
- $2.30M
- +$277.5K (+13.7%) vs. Q4 2023
- New holders
- 1
- 6 more added
- Sold out
- 2
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LSTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $3.70M |
| Q1 2026 | 34 | $7.06M |
| Q4 2025 | 25 | $1.36M |
| Q3 2025 | 21 | $1.93M |
| Q2 2025 | 20 | $2.26M |
| Q1 2025 | 22 | $1.84M |
| Q4 2024 | 21 | $2.33M |
| Q3 2024 | 20 | $2.30M |
| Q2 2024 | 22 | $2.61M |
| Q1 2024 | 21 | $2.30M |
| Q4 2023 | 22 | $2.03M |
| Q3 2023 | 21 | $1.46M |
| Q2 2023 | 22 | $2.51M |
| Q1 2023 | 21 | $2.08M |
| Q4 2022 | 24 | $1.83M |
| Q3 2022 | 22 | $2.17M |
| Q2 2022 | 36 | $5.00M |
| Q1 2022 | 34 | $6.13M |
| Q4 2021 | 36 | $7.33M |
| Q3 2021 | 34 | $9.41M |
| Q2 2021 | 29 | $10.1M |
| Q1 2021 | 33 | $12.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Lisata Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 284,669 | $888.2K | 0.59% | +14,830+5.5% | Added |
| Vanguard Group Inc | 181,692 | $566.9K | 0.00% | +4,727+2.7% | Added |
| Renaissance Technologies LLC | 99,522 | $311.0K | 0.00% | +2,300+2.4% | Added |
| BlackRock Inc. | 56,013 | $174.8K | 0.00% | −237−0.4% | Reduced |
| Geode Capital Management, LLC | 44,350 | $138.4K | 0.00% | +960+2.2% | Added |
| State Street Corp | 14,348 | $44.8K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 11,697 | $36.5K | 0.00% | +11,697 | New |
| Cook Wealth Management Group LLC | 12,175 | $35.7K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,719 | $33.4K | 0.00% | −23,030−68.2% | Reduced |
| HighTower Advisors, LLC | 10,044 | $31.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 9,658 | $30.1K | 0.00% | −40.0% | Reduced |
| Morgan Stanley | 2,550 | $7.96K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 853 | $2.66K | 0.00% | −176−17.1% | Reduced |
| Founders Capital Management | 333 | $1.04K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 54 | $168 | 0.00% | +1+1.9% | Added |
| JPMorgan Chase & Co | 16 | $50 | 0.00% | +5+45.5% | Added |
| Steward Partners Investment Advisory, LLC | 6 | $19 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 4 | $12 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $3 | 0.00% | −235−99.6% | Reduced |
| Advisor Group Holdings, Inc. | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 52 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,131−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −20−100.0% | Sold out |